2025-09-04 - Analysis Report
Okay, here's an analysis of Natera Inc. (NTRA), incorporating the data you've provided, presented in a report format suitable for English presentation:

## Natera Inc. (NTRA) Stock Analysis Report

**Company Overview:** Natera Inc. is a genetic testing company focused on non-invasive prenatal testing (NIPT) and cancer diagnostics.

### 1.  Relative Performance & Alpha/Beta Analysis

**Key Figures:**

*   **NTRA Cumulative Return:** 160.84%
*   **VOO (S&P 500) Cumulative Return:** 99.47%
*   **Spread (NTRA - VOO):** 57.2
*   **Spread Range:** Max 631.9, Min -39.3
*   **Relative Spread Position:** 14.4

**Analysis:** NTRA has significantly outperformed the S&P 500 (VOO) over the analyzed period. The current spread of 57.2 indicates NTRA's performance is well above the benchmark. However, the "Relative Spread Position" of 14.4 suggests that while positive, the outperformance is not at its historical peak.

**Alpha/Beta Analysis Table:**

| Year       | CAGR   | MDD   | Alpha   | Beta   | Cap(B) |
|------------|--------|-------|---------|--------|--------|
| 2015-2017  | -6.0%  | 62.4% | -31.0%  | 0.0    | 1.2    |
| 2016-2018  | 29.0%  | 80.1% | 11.0%   | 0.0    | 1.9    |
| 2017-2019  | 159.0% | 80.1% | 130.0%  | 1.2    | 4.6    |
| 2018-2020  | 530.0% | 80.1% | 510.0%  | 0.3    | 13.7   |
| 2019-2021  | 355.0% | 62.9% | 307.0%  | 0.2    | 12.8   |
| 2020-2022  | -119.0%| 62.9% | -121.0% | 0.2    | 5.5    |
| 2021-2023  | -482.0%| 69.9% | -500.0% | 1.1    | 8.6    |
| 2022-2024  | -75.0% | 70.6% | -100.0% | 1.2    | 21.7   |
| 2023-2025  | 110.0% | 76.1% | 59.0%   | 0.8    | 23.2   |

**Analysis:**

*   **CAGR Variability:** The Compound Annual Growth Rate (CAGR) shows significant volatility, ranging from -482% to +530%. This indicates periods of substantial growth and severe declines.
*   **MDD:** Maximum Drawdown (MDD) is consistently high, ranging from 62.4% to 80.1%.  This highlights the stock's high risk profile.
*   **Alpha:**  Alpha fluctuates significantly, mirroring the CAGR.  High positive alpha values (e.g., 510% in 2018-2020) indicate substantial outperformance relative to the market. Negative alpha values indicate underperformance.
*   **Beta:** Beta values are generally low, suggesting NTRA's price movements are not strongly correlated with the S&P 500.  The data indicates that Natera's returns are driven more by company-specific factors rather than overall market trends.
*   **Cap:** Market capitalization has grown over time, reflecting the company's expansion, but its volatility is noteworthy.

### 2. Recent Price Action

*   **Current Price:** 169.212
*   **Previous Close:** 169.34
*   **Change:** -0.08
*   **5-Day Moving Average:** 166.8184
*   **20-Day Moving Average:** 158.6656
*   **60-Day Moving Average:** 156.6076

**Analysis:** The current price is slightly down from the previous close.  The 5-day moving average is above the 20-day and 60-day moving averages, suggesting a short-term upward trend. The fact that all three moving averages are trending upwards indicates positive momentum over the short, medium, and long term.

### 3. Market Risk Indicators & Expected Return

*   **Market Risk Indicator (MRI):** 0.3403 (Low Risk)
*   **RSI:** 65.15
*   **PPO:** 0.6791
*   **Hybrid Signal:** "cash_0%_Buy 80% of cash (5 shares - Caution - MRI:0.34) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-09-02)"
*   **Recent (20-day) Relative Spread Change:** 0.8 (+)
*   **Expected Return:** 96.3%

**Analysis:**

*   **MRI:** A low MRI suggests that the overall market conditions are relatively stable.
*   **RSI:** An RSI of 65.15 is approaching overbought territory (typically above 70), suggesting the stock may be due for a pullback.
*   **PPO:** A positive PPO indicates that the short-term moving average is above the long-term moving average, confirming the upward trend.
*   **Hybrid Signal:** The hybrid signal suggests buying 80% of available cash and investing monthly, with a caution note due to the MRI.
*   **Recent Relative Spread Change:** The positive change in relative spread over the past 20 days confirms the recent upward momentum.
*   **Expected Return:** A high expected return of 96.3% suggests a potentially significant outperformance of the S&P 500 over a long-term investment horizon (2+ years).

The slight price decrease (change of -0.08) isn't significant enough to warrant a "volatility issue" warning.

### 4. Recent News & Significant Events

*   **2025-09-03:** Major business developments, regulatory changes, or market events.
*   **2025-09-04:** Analyst discussions on performance and outlook.
*   **2025-08-31:** Notable stock volatility due to recent news, earnings, or executive actions.
*   **2025-09-01:** Market experts highlight both risks and opportunities.

**Analysis:** Recent news indicates that NTRA is subject to various market influences, including business developments, analyst opinions, and volatility. This suggests that investors should monitor news and company announcements closely.

### 5. Recent Earnings Analysis

| 날짜       | EPS   | 매출       |
|------------|-------|------------|
| 2025-08-08 | -0.74 | 0.55 B$    |
| 2025-05-09 | -0.5  | 0.50 B$    |
| 2024-11-12 | -0.26 | 0.44 B$    |
| 2024-08-09 | -0.3  | 0.41 B$    |
| 2025-08-08 | -0.3  | 0.41 B$    |

**Analysis:**

*   **EPS:** Earnings per share (EPS) are consistently negative, indicating that the company is not currently profitable.
*   **Revenue:** Revenue has been generally increasing over the past quarters.

The combination of negative EPS and growing revenue suggests that while the company is increasing its sales, it has not yet achieved profitability. This could be due to high operating costs, R&D expenses, or other factors.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-06-30 | $0.55B  | 63.41%        |
| 2025-03-31 | $0.50B  | 63.12%        |
| 2024-12-31 | $0.48B  | 62.94%        |
| 2024-09-30 | $0.44B  | 61.79%        |
| 2024-06-30 | $0.41B  | 58.83%        |

**Capital and Profitability:**

| Quarter    | Equity   | ROE      |
|------------|----------|----------|
| 2025-06-30 | $1.25B   | -8.10%   |
| 2025-03-31 | $1.24B   | -5.40%   |
| 2024-12-31 | $1.20B   | -4.50%   |
| 2024-09-30 | $0.88B   | -3.60%   |
| 2024-06-30 | $0.84B   | -4.48%   |

**Analysis:**

*   **Revenue and Profit Margin:** Revenue has been increasing steadily. The profit margin is high and relatively stable, indicating efficient cost management relative to sales.
*   **Capital and Profitability:** Equity has been increasing, suggesting the company is building its asset base. However, Return on Equity (ROE) is negative, reflecting the company's current unprofitability, despite the growing equity base.

### 7. Overall Summary

Natera (NTRA) has shown strong outperformance compared to the S&P 500, but with significant volatility and a high-risk profile.  Recent price action is positive, and the hybrid signal suggests a cautious buy. While revenue is growing, the company is not yet profitable (negative EPS and ROE). Recent news indicates the stock is sensitive to company-specific events and market dynamics.

**Investment Considerations:**

*   **Growth Potential:** High expected return (96.3%) suggests significant long-term growth potential.
*   **Risk Tolerance:** High MDD and volatile Alpha/Beta values indicate the stock is suitable for investors with a high-risk tolerance.
*   **Profitability:** The lack of current profitability is a concern. Monitor EPS and ROE closely for signs of improvement.
*   **News Monitoring:** Stay informed about company announcements, regulatory changes, and industry trends.

**Disclaimer:** This analysis is based on the provided data and is not financial advice.  Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions.
